These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33929058)

  • 1. Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Gowda L; Vege S; Kessler D; Shaz B; Westhoff CM
    Transfusion; 2021 Jul; 61(7):2008-2013. PubMed ID: 33929058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemoglobin S testing using HEA BeadChip™ technology: Lifeblood comparison with clinical diagnosis.
    Wong P; Baidya S; Daly J; Powley T
    Vox Sang; 2022 Aug; 117(8):1001-1005. PubMed ID: 35522596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease.
    Hajjaj OI; Cserti-Gazdewich C; Dumevska L; Hanna M; Lau W; Lieberman L;
    Transfusion; 2023 Mar; 63(3):507-514. PubMed ID: 36519666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of sickle cell trait in Jharkhand state in India: Is it the zone of contact between two geographically and ethnically distinct populations in India?
    Nagar R; Raman R
    J Biosci; 2015 Sep; 40(3):539-47. PubMed ID: 26333400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hemoglobin S trait among blood donors: a cross-sectional study.
    Antwi-Baffour S; Asare RO; Adjei JK; Kyeremeh R; Adjei DN
    BMC Res Notes; 2015 Oct; 8():583. PubMed ID: 26480855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Diabetes Mellitus on Sickle Hemoglobin Quantitation in Sickle Cell Trait.
    Li SH; Harro D; Alfsen J; Bolterman J; Ketha H; Schroeder LF; Giacherio DA; Keren DF
    Am J Clin Pathol; 2018 Jul; 150(2):105-115. PubMed ID: 29850781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Hemoglobinopathies (β-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Mir SA; Alshehri BM; Alaidarous M; Banawas SS; Dukhyil AAAB; Alturki MK
    Hemoglobin; 2020 Jan; 44(1):47-50. PubMed ID: 32091272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hb Haaglanden: a new nonsickling β7Glu>Val variant. Consequences for basic diagnostics, screening, and risk assessment when dealing with HbS-like variants.
    Harteveld CL; Ponjee G; Bakker-Verweij M; Arkesteijn SG; Phylipsen M; Giordano PC
    Int J Lab Hematol; 2012 Oct; 34(5):551-5. PubMed ID: 22494447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta globin haplotypes in hemoglobin S carriers in Colombia].
    Durán CL; Morales OL; Echeverri SJ; Isaza M
    Biomedica; 2012; 32(1):103-11. PubMed ID: 23235792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration.
    Stroncek DF; Rainer T; Sharon V; Byrne KM; Noguchi CT; Klein HG; Schechter AN; Leitman SF
    Transfusion; 2002 Nov; 42(11):1466-72. PubMed ID: 12421220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries.
    Randolph TR; Wheelhouse J
    Clin Lab Sci; 2012; 25(1):26-34. PubMed ID: 22458046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle solubility test to screen for sickle cell trait: what's the harm?
    Tubman VN; Field JJ
    Hematology Am Soc Hematol Educ Program; 2015; 2015():433-5. PubMed ID: 26637754
    [No Abstract]   [Full Text] [Related]  

  • 15. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B
    Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
    J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological status of blood-donors with sickle cell trait and alpha thalassaemia in northern Nigeria.
    Niazi GA; Fleming AF
    East Afr Med J; 1989 Dec; 66(12):824-9. PubMed ID: 2612414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell trait diagnosis: clinical and social implications.
    Naik RP; Haywood C
    Hematology Am Soc Hematol Educ Program; 2015; 2015(1):160-7. PubMed ID: 26637716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pitfalls in the diagnosis of Hb Handsworth in areas with high prevalence of HbS.
    Al Zadjali S; Al-Riyami AZ; Gravell D; Al Haddabi H; Al Rawahi M; Al Falahi K; Daar S
    Int J Lab Hematol; 2014 Aug; 36(4):488-92. PubMed ID: 24165563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.